click below
click below
Normal Size Small Size show me how
Diabetic Drugs MOA
oral medications
| Question | Answer |
|---|---|
| Nateglinide | Stimulate insulin secretion.Nonsulfonylurea secretagogues (Glinides)(Starlix) |
| Repaglinide | Stimulate insulin secretion.Nonsulfonylurea secretagogues (Glinides)(Prandin) |
| Acetohexamide | Stimulate insulin secretion. May decrease hepatic glucose output and enhance peripheral glucose utilization.1st Sulfonylureas (Dymelor) |
| Chlorpropamide | Stimulate insulin secretion. May decrease hepatic glucose output and enhance peripheral glucose utilization.1st Sulfonylureas (Diabinese) |
| Tolazamide | Stimulate insulin secretion. May decrease hepatic glucose output and enhance peripheral glucose utilization.1st Sulfonylureas (Tolinase) |
| Tolbutamide | Stimulate insulin secretion. May decrease hepatic glucose output and enhance peripheral glucose utilization.1st Sulfonylureas (Orinase) |
| Glimepiride | Stimulate insulin secretion. May decrease hepatic glucose output and enhance peripheral glucose utilization.2nd Sulfonylureas (Amaryl) |
| Glipizide | Stimulate insulin secretion. May decrease hepatic glucose output and enhance peripheral glucose utilization.2nd Sulfonylureas (Glucotrol) |
| Glyburide | Stimulate insulin secretion. May decrease hepatic glucose output and enhance peripheral glucose utilization.2nd Sulfonylureas (Diabeta, Micronase) |
| Exenatide | Stimulates insulin secretion, delays gastric emptying, reduces postprandial glucagon levels, improved satietyGlucagon-like peptide -1 receptor agonists/Incretin Mimetic (Byetta) |
| Sitagliptin | Stimulates insulin secretion and reduces postprandial glucagon levelsDPP-4 Inhibitors (Januvia) |
| Pramlintide | Stimulates insulin secretion, delays gastric emptying, reduces postprandial glucagon levels, improved satietyAmylin mimetic (Symlin) |
| Metformin | ↓ Hepatic glucose output;↑ Peripheral glucose uptakeBiguanides (Glucophage) |
| Pioglitazone | Enhance insulin action in periphery; increase glucose utilization by muscle and fat tissue; decrease hepatic glucose outputThiazolidinediones (Actos) |
| Rosiglitazone | Enhance insulin action in periphery; increase glucose utilization by muscle and fat tissue; decrease hepatic glucose outputThiazolidinediones (Avandia) |
| Miglitol | Slow absorption of complex carbohydrates.α-Glucosidase inhibitors (Glyset) |
| Acarbose | Slow absorption of complex carbohydrates.α-Glucosidase inhibitors (Precose) |